What is Sotera Health Co's earnings per share (EPS)?

Sotera Health Co (SHC) reported diluted earnings per share of $0.27 for fiscal year 2025. This represents a 68.8% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Sotera Health Co Financials

SHC

Source SEC Filings (10-K/10-Q) Updated Dec 31, 2025 Currency USD FYE December

This page shows Sotera Health Co (SHC) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial Profile 43/100

Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores

Growth

Sotera Health Co's revenue grew 5.7% year-over-year to $1.2B, a solid pace of expansion. This earns a growth score of 43/100.

Leverage

Sotera Health Co has a moderate D/E ratio of 3.51. This balance of debt and equity financing earns a leverage score of 30/100.

Liquidity

Sotera Health Co's current ratio of 2.46 indicates adequate short-term liquidity, earning a score of 46/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Sotera Health Co has a free cash flow margin of 12.8%, earning a moderate score of 57/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Sotera Health Co's ROE of 12.9% shows moderate profitability relative to equity, earning a score of 40/100. This is up from 11.0% the prior year.

Piotroski F-Score Neutral

6/9

Sotera Health Co passes 6 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

3.68x

For every $1 of reported earnings, Sotera Health Co generates $3.68 in operating cash flow ($287.2M OCF vs $77.9M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.2B

YoY+5.7%

5Y CAGR+7.3%

Sotera Health Co generated $1.2B in revenue in fiscal year 2025. This represents an increase of 5.7% from the prior year.

EBITDA

N/A

Net Income

$77.9M

YoY+75.6%

Sotera Health Co reported $77.9M in net income in fiscal year 2025. This represents an increase of 75.6% from the prior year.

EPS (Diluted)

$0.27

YoY+68.8%

Sotera Health Co earned $0.27 per diluted share (EPS) in fiscal year 2025. This represents an increase of 68.8% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$149.2M

YoY+230.8%

5Y CAGR+17.3%

Sotera Health Co generated $149.2M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 230.8% from the prior year.

Cash & Debt

$344.6M

YoY+24.3%

5Y CAGR+27.5%

Sotera Health Co held $344.6M in cash against $2.1B in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

N/A

Margins & Returns

Gross Margin

55.5%

YoY+0.7pp

5Y CAGR+1.3pp

Sotera Health Co's gross margin was 55.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 0.7 percentage points from the prior year.

Operating Margin

N/A

Net Margin

6.7%

YoY+2.7pp

5Y CAGR+11.4pp

Sotera Health Co's net profit margin was 6.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 2.7 percentage points from the prior year.

Return on Equity

12.9%

YoY+1.9pp

5Y CAGR+21.4pp

Sotera Health Co's ROE was 12.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 1.9 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$138.0M

YoY-22.9%

5Y CAGR+20.9%

Sotera Health Co invested $138.0M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 22.9% from the prior year.

SHC Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$1.2B+5.7%	$1.1B+4.9%	$1.0B+4.5%	$1.0B+7.8%	$931.5M+13.9%	$818.2M
Cost of Revenue	$518.1M+4.0%	$498.1M+5.5%	$472.1M+5.7%	$446.7M+8.2%	$412.8M+10.2%	$374.6M
Gross Profit	$645.5M+7.2%	$602.3M+4.4%	$577.2M+3.6%	$557.0M+7.4%	$518.7M+16.9%	$443.6M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$252.8M+4.2%	$242.6M+2.5%	$236.7M-3.7%	$245.7M+24.0%	$198.2M+11.0%	$178.5M
Operating Income	N/A	$297.6M+7.6%	$276.7M+11.4%	$248.3M-3.3%	$256.7M+24.6%	$206.0M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$69.6M+0.1%	$69.5M+27.1%	$54.7M+672.8%	-$9.5M-116.3%	$58.6M+4380.1%	-$1.4M
Net Income	$77.9M+75.6%	$44.4M-13.6%	$51.4M+122.0%	-$233.6M-299.8%	$116.9M+402.7%	-$38.6M
EPS (Diluted)	$0.27+68.8%	$0.16-11.1%	$0.18+121.7%	$-0.83-302.4%	$0.41+356.2%	$-0.16

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Revenue	$303.4M-2.5%	$311.3M+5.8%	$294.3M+15.6%	$254.5M-12.3%	$290.2M+1.7%	$285.5M+3.2%	$276.6M+11.5%	$248.2M
Cost of Revenue	$137.5M+2.8%	$133.8M+4.7%	$127.7M+7.2%	$119.1M-5.4%	$125.8M-1.3%	$127.4M+2.9%	$123.8M+2.3%	$121.1M
Gross Profit	$165.9M-6.6%	$177.6M+6.6%	$166.6M+23.0%	$135.4M-17.6%	$164.4M+4.0%	$158.0M+3.4%	$152.8M+20.2%	$127.1M
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$57.5M-9.1%	$63.3M-8.1%	$68.9M+9.2%	$63.1M+2.0%	$61.8M-0.3%	$62.0M+2.4%	$60.6M+4.1%	$58.2M
Operating Income	N/A	N/A	N/A	N/A	$87.1M+8.2%	$80.5M+4.8%	$76.8M+44.4%	$53.2M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$35.6M+45.3%	$24.5M+124.4%	$10.9M+799.6%	-$1.6M-104.8%	$32.6M+26.7%	$25.8M+303.2%	$6.4M+36.2%	$4.7M
Net Income	$34.8M-28.0%	$48.4M+507.9%	$8.0M+160.0%	-$13.3M-207.6%	$12.3M-27.5%	$17.0M+94.2%	$8.8M+38.4%	$6.3M
EPS (Diluted)	N/A	$0.17+466.7%	$0.03+160.0%	$-0.05	N/A	$0.06+100.0%	$0.03+50.0%	$0.02

SHC Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$3.3B+6.2%	$3.1B-1.9%	$3.1B+0.4%	$3.1B+11.8%	$2.8B+1.0%	$2.8B
Current Assets	$613.4M+16.6%	$526.0M-5.6%	$557.2M-13.6%	$645.0M+86.4%	$346.0M+9.8%	$315.0M
Cash & Equivalents	$344.6M+24.3%	$277.2M-6.5%	$296.4M-25.0%	$395.2M+269.6%	$106.9M+4.4%	$102.4M
Inventory	$54.4M+10.6%	$49.2M+1.7%	$48.3M+30.1%	$37.1M-31.6%	$54.3M+59.2%	$34.1M
Accounts Receivable	$139.3M-0.7%	$140.3M-5.0%	$147.7M+24.7%	$118.5M+9.5%	$108.2M+17.9%	$91.7M
Goodwill	$1.1B+2.0%	$1.1B-2.7%	$1.1B+0.9%	$1.1B-1.7%	$1.1B+0.4%	$1.1B
Total Liabilities	$2.7B-0.4%	$2.7B-0.7%	$2.7B-2.9%	$2.8B+25.6%	$2.2B-4.5%	$2.3B
Current Liabilities	$249.6M+30.7%	$191.0M-17.2%	$230.7M-70.9%	$791.6M+391.2%	$161.2M+14.6%	$140.6M
Long-Term Debt	$2.1B-3.7%	$2.2B-0.7%	$2.2B+27.3%	$1.7B+0.2%	$1.7B-4.5%	$1.8B
Total Equity	$606.0M+49.7%	$404.9M-8.7%	$443.7M+26.7%	$350.2M-40.2%	$586.1M+29.6%	$452.3M
Retained Earnings	-$532.1M+12.8%	-$610.0M+6.8%	-$654.4M+7.3%	-$705.8M-49.5%	-$472.2M+19.8%	-$589.1M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Total Assets	$3.3B+2.4%	$3.2B-1.0%	$3.2B+3.8%	$3.1B+0.8%	$3.1B-2.4%	$3.1B+3.0%	$3.1B-0.1%	$3.1B
Current Assets	$613.4M+6.2%	$577.8M-5.0%	$608.2M+9.6%	$555.0M+5.5%	$526.0M-6.7%	$563.6M+13.2%	$497.7M+2.2%	$487.2M
Cash & Equivalents	$344.6M+15.2%	$299.2M-10.0%	$332.4M+9.2%	$304.4M+9.8%	$277.2M-9.6%	$306.7M+24.6%	$246.1M-5.8%	$261.1M
Inventory	$54.4M+9.0%	$49.9M-16.8%	$59.9M-1.8%	$61.0M+24.2%	$49.2M-8.4%	$53.6M-7.3%	$57.9M+12.7%	$51.3M
Accounts Receivable	$139.3M-2.1%	$142.4M+4.3%	$136.6M+6.6%	$128.1M-8.7%	$140.3M+7.8%	$130.1M+5.2%	$123.7M+11.3%	$111.1M
Goodwill	$1.1B+0.4%	$1.1B-0.5%	$1.1B+1.9%	$1.1B+0.3%	$1.1B-2.1%	$1.1B+0.6%	$1.1B-0.4%	$1.1B
Total Liabilities	$2.7B+0.8%	$2.6B-2.6%	$2.7B+0.8%	$2.7B+0.6%	$2.7B-0.4%	$2.7B+1.7%	$2.6B+0.2%	$2.6B
Current Liabilities	$249.6M+3.0%	$242.4M-1.6%	$246.3M+9.0%	$226.0M+18.3%	$191.0M-2.3%	$195.5M+15.3%	$169.6M+11.4%	$152.3M
Long-Term Debt	$2.1B-0.1%	$2.1B-3.3%	$2.2B-0.1%	$2.2B-0.1%	$2.2B-0.1%	$2.2B-0.1%	$2.2B-0.5%	$2.2B
Total Equity	$606.0M+10.1%	$550.5M+7.7%	$511.3M+23.5%	$414.1M+2.3%	$404.9M-13.9%	$470.2M+11.2%	$422.8M-1.5%	$429.4M
Retained Earnings	-$532.1M+6.1%	-$566.9M+7.9%	-$615.3M+1.3%	-$623.3M-2.2%	-$610.0M+2.0%	-$622.4M+2.7%	-$639.4M+1.4%	-$648.1M

SHC Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$287.2M+28.1%	$224.2M+251.7%	-$147.7M-153.1%	$278.0M-1.3%	$281.5M+133.5%	$120.6M
Capital Expenditures	$138.0M-22.9%	$179.1M-16.7%	$215.0M+17.9%	$182.4M+78.5%	$102.2M+90.9%	$53.5M
Free Cash Flow	$149.2M+230.8%	$45.1M+112.4%	-$362.7M-479.5%	$95.6M-46.7%	$179.4M+167.4%	$67.1M
Investing Cash Flow	-$135.1M+24.5%	-$179.0M+16.7%	-$214.9M-18.1%	-$181.9M-13.8%	-$159.8M-0.7%	-$158.7M
Financing Cash Flow	-$100.5M-98.8%	-$50.6M-119.0%	$266.0M+34.5%	$197.8M+268.6%	-$117.3M-259.7%	$73.4M
Dividends Paid	N/A	N/A	N/A	N/A	$0	$0
Share Buybacks	N/A	N/A	N/A	$0	$0-100.0%	$34.0M

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Operating Cash Flow	$103.1M+44.9%	$71.2M+23.9%	$57.4M+3.4%	$55.5M-0.4%	$55.7M-42.8%	$97.5M+59.0%	$61.3M+532.0%	$9.7M
Capital Expenditures	$50.7M+40.2%	$36.2M+15.8%	$31.2M+56.8%	$19.9M-69.8%	$65.9M+81.0%	$36.4M-13.2%	$41.9M+20.2%	$34.9M
Free Cash Flow	$52.4M+49.8%	$35.0M+33.6%	$26.2M-26.4%	$35.6M+450.7%	-$10.2M-116.6%	$61.1M+215.2%	$19.4M+176.9%	-$25.2M
Investing Cash Flow	-$50.7M-52.1%	-$33.3M-6.7%	-$31.2M-57.1%	-$19.9M+69.8%	-$65.9M-81.2%	-$36.4M+13.3%	-$41.9M-20.3%	-$34.9M
Financing Cash Flow	-$8.2M+89.4%	-$77.3M-1015.5%	-$6.9M+14.3%	-$8.1M-23.5%	-$6.5M-146.7%	-$2.7M+91.0%	-$29.4M-146.4%	-$11.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

SHC Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	55.5%+0.7pp	54.7%-0.3pp	55.0%-0.5pp	55.5%-0.2pp	55.7%+1.5pp	54.2%
Operating Margin	N/A	27.1%+0.7pp	26.4%+1.6pp	24.7%-2.8pp	27.6%+2.4pp	25.2%
Net Margin	6.7%+2.7pp	4.0%-0.9pp	4.9%+28.2pp	-23.3%-35.8pp	12.6%+17.3pp	-4.7%
Return on Equity	12.9%+1.9pp	11.0%-0.6pp	11.6%+78.3pp	-66.7%-86.6pp	19.9%+28.5pp	-8.5%
Return on Assets	2.4%+0.9pp	1.5%-0.2pp	1.6%+9.1pp	-7.5%-11.7pp	4.2%+5.6pp	-1.4%
Current Ratio	2.46-0.3	2.75+0.3	2.42+1.6	0.81-1.3	2.15-0.1	2.24
Debt-to-Equity	3.51-1.9	5.45+0.4	5.01+0.0	4.99+2.0	2.97-1.1	4.03
FCF Margin	12.8%+8.7pp	4.1%+38.7pp	-34.6%-44.1pp	9.5%-9.7pp	19.3%+11.1pp	8.2%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24
Gross Margin	54.7%-2.4pp	57.0%+0.4pp	56.6%+3.4pp	53.2%-3.4pp	56.6%+1.3pp	55.4%+0.1pp	55.2%+4.0pp	51.2%
Operating Margin	N/A	N/A	N/A	N/A	30.0%+1.8pp	28.2%+0.4pp	27.8%+6.3pp	21.4%
Net Margin	11.5%-4.1pp	15.6%+12.8pp	2.7%+7.9pp	-5.2%-9.5pp	4.3%-1.7pp	5.9%+2.8pp	3.2%+0.6pp	2.5%
Return on Equity	5.8%-3.0pp	8.8%+7.2pp	1.6%+4.8pp	-3.2%-6.2pp	3.0%-0.6pp	3.6%+1.6pp	2.1%+0.6pp	1.5%
Return on Assets	1.1%-0.5pp	1.5%+1.3pp	0.3%+0.7pp	-0.4%-0.8pp	0.4%-0.1pp	0.5%+0.3pp	0.3%+0.1pp	0.2%
Current Ratio	2.46+0.1	2.38-0.1	2.47+0.0	2.46-0.3	2.75-0.1	2.88-0.1	2.93-0.3	3.20
Debt-to-Equity	3.51-0.4	3.87-0.4	4.31-1.0	5.33-0.1	5.45+0.8	4.70-0.5	5.24+0.1	5.18
FCF Margin	17.3%+6.0pp	11.2%+2.3pp	8.9%-5.1pp	14.0%+17.5pp	-3.5%-24.9pp	21.4%+14.4pp	7.0%+17.2pp	-10.2%

Similar Companies

Radnet RDNT

$4.3B

GeneDx Holdings Corp WGS

$1.9B

Charles Riv Labs Intl Inc CRL

$8.6B

Guardant Health GH

$12.3B

Revvity Inc RVTY

$9.9B

Frequently Asked Questions

What is Sotera Health Co's annual revenue?

Sotera Health Co (SHC) reported $1.2B in total revenue for fiscal year 2025. This represents a 5.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Sotera Health Co's revenue growing?

Sotera Health Co (SHC) revenue grew by 5.7% year-over-year, from $1.1B to $1.2B in fiscal year 2025.

Is Sotera Health Co profitable?

Yes, Sotera Health Co (SHC) reported a net income of $77.9M in fiscal year 2025, with a net profit margin of 6.7%.

How much debt does Sotera Health Co have?

As of fiscal year 2025, Sotera Health Co (SHC) had $344.6M in cash and equivalents against $2.1B in long-term debt.

What is Sotera Health Co's gross margin?

Sotera Health Co (SHC) had a gross margin of 55.5% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Sotera Health Co's net profit margin?

Sotera Health Co (SHC) had a net profit margin of 6.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Sotera Health Co's return on equity (ROE)?

Sotera Health Co (SHC) has a return on equity of 12.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Sotera Health Co's free cash flow?

Sotera Health Co (SHC) generated $149.2M in free cash flow during fiscal year 2025. This represents a 230.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Sotera Health Co's operating cash flow?

Sotera Health Co (SHC) generated $287.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Sotera Health Co's total assets?

Sotera Health Co (SHC) had $3.3B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Sotera Health Co's capital expenditures?

Sotera Health Co (SHC) invested $138.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

What is Sotera Health Co's current ratio?

Sotera Health Co (SHC) had a current ratio of 2.46 as of fiscal year 2025, which is generally considered healthy.

What is Sotera Health Co's debt-to-equity ratio?

Sotera Health Co (SHC) had a debt-to-equity ratio of 3.51 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Sotera Health Co's return on assets (ROA)?

Sotera Health Co (SHC) had a return on assets of 2.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Sotera Health Co's Piotroski F-Score?

Sotera Health Co (SHC) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Sotera Health Co's earnings high quality?

Sotera Health Co (SHC) has an earnings quality ratio of 3.68x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Sotera Health Co?

Sotera Health Co (SHC) scores 43 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.